Retaglutide is a novel GLP-1 receptor agonist currently under investigation for the treatment of type 2 diabetes. This drug works by enhancing the effects of glucagon-like peptide-1 (GLP-1), a naturally occurring https://tedooin610755.blog-gold.com/53559227/trelaglutide-exploring-a-new-therapy-for-chronic-diseases